Effects of interferon-alpha monotherapy on hepatic drug metabolism in cancer patients.
Open Access
- 1 September 1993
- journal article
- clinical trial
- Published by Wiley
- Vol. 36 (3) , 229-235
- https://doi.org/10.1111/j.1365-2125.1993.tb04222.x
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Interferon suppresses erythromycin metabolism in rats and human subjectsHepatology, 1993
- Depression of Drug-metabolizing Activity in the Human Liver by Interferon-βHepatology, 1993
- Metronidazole and Antipyrine as Probes for the Study of Foreign Compound MetabolismBasic & Clinical Pharmacology & Toxicology, 1990
- Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiaeBiochemistry, 1989
- Depression of liver drug metabolism and increase in plasma fibrinogen by interleukin 1 and tumor necrosis factor: A comparison with lymphotoxin and interferonInternational Journal of Immunopharmacology, 1988
- INHIBITION OF THEOPHYLLINE METABOLISM BY INTERFERONThe Lancet, 1987
- Interleukin-1 (IL-1) depresses cytochrome P450 levels and activities in miceLife Sciences, 1987
- Enhanced xanthine oxidase activity in mice treated with interferon and interferon inducersBiochemical and Biophysical Research Communications, 1984
- Homogeneous interferon from E. coli depresses hepatic cytochrome P-450 and drug biotransformationBiochemical and Biophysical Research Communications, 1982
- Depression of hepatic cytochrome P-450-dependent monooxygenase systems with administered interferon inducing agentsBiochemical and Biophysical Research Communications, 1976